arginine and Hyperlipoproteinemia Type II

arginine has been researched along with Hyperlipoproteinemia Type II in 22 studies

Research

Studies (22)

TimeframeStudies, this research(%)All Research%
pre-19901 (4.55)18.7374
1990's10 (45.45)18.2507
2000's7 (31.82)29.6817
2010's4 (18.18)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Angelin, B; Eriksson, M; Kovamees, O; Pernow, J; Shemyakin, A1
Fajkusová, L; Freiberger, T; Pavloušková, J; Réblová, K; Tichý, L1
Beyer-Westendorf, J; Bornstein, SR; Bramlage, P; Jabs, N; Julius, U; Kuhlisch, E; Schellong, SM; Seitz, W1
Armstrong, VW; Helfmann, J; Hintze, E; Konstantinides, S; Koziolek, MJ; Lange, K; Mueller, GA; Rossenbach, J; Schmitto, JD1
Florkowski, CM; Frampton, CM; George, PM; Molyneux, SL; Reinheimer, AM; Scott, RS; Young, JM1
Knuuti, J; Laakso, J; Laaksonen, R; Laine, H; Päivä, H; Raitakari, OT1
De Nigris, F; De Rosa, G; Di Tuoro, F; Guarino, C; Ignarro, LJ; Lerman, LO; Mansueto, G; Napoli, C; Pignalosa, O; Rossi, L; Sica, V; Williams-Ignarro, S1
Benn, M; Jensen, G; Jensen, HK; Nordestgaard, BG; Steffensen, R; Tybjaerg-Hansen, A1
Besio, D; Chiu, E; Engler, MB; Engler, MM; Malloy, M; Mietus-Snyder, M; Morrow, J; Paul, S; Ridker, P; Rifai, N; Stuehlinger, M1
Jehlicka, P; Mayer, O; Racek, J; Siala, K; Stožický, F; Trefil, L; Varvařovská, J1
Descovich, G; Fragiacomo, C; Gatti, E; Noseda, G; Sirtori, CR1
de Bruin, TW; Koomans, HA; Rabelink, TJ; Stroes, ES1
Dempsey, G; Guernsey, DL; Morash, B; Nassar, BA; Tan, MH1
Keller, C; Rauh, G; Schewe, CK; Schuster, H; Stratmann, G; Wolfram, G; Zöllner, N1
Choong, ML; Khaw, MC; Khoo, KL; Koay, ES; Sethi, SK1
Arnold, K; Boren, J; Innerarity, TL; Lee, I; Taylor, S; Zhu, W1
Banga, JD; de Bruin, T; de Valk, H; Erkelens, W; Koomans, H; Rabelink, T; Stroes, E; van Rijn, H1
Chen, M; Feussner, G; Fisher, E; Hoffmann, MM; März, W; Nauck, M; Scharnagl, H; Wieland, H1
Boer, P; Hijmering, M; Kastelein, J; Koomans, H; Lagerwerf, F; Rabelink, T; Stroes, E; van Rijn, H; Verhaar, M; Versluis, K; Wever, R1
Gutierrez, G; Jobs, J; Korte, A; Manns, MP; Schmidt, H; Schneider, A; Stuhrmann, M1
Firoozmand, S; Oleesky, DA; Penney, MD1
Fischer, J; Keller, C; Rauh, G; Schuster, H; Wolfram, G; Zöllner, N1

Trials

4 trial(s) available for arginine and Hyperlipoproteinemia Type II

ArticleYear
Docosahexaenoic acid restores endothelial function in children with hyperlipidemia: results from the EARLY study.
    International journal of clinical pharmacology and therapeutics, 2004, Volume: 42, Issue:12

    Topics: Adolescent; Adult; Arginine; Biomarkers; Child; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Cross-Over Studies; Docosahexaenoic Acids; Double-Blind Method; Endothelium, Vascular; Humans; Hyperlipidemia, Familial Combined; Hyperlipoproteinemia Type II; Hypolipidemic Agents; Inflammation; Oxidative Stress; Phenotype; Triglycerides

2004
Asymmetric dimethylarginine and the effect of folate substitution in children with familial hypercholesterolemia and diabetes mellitus type 1.
    Physiological research, 2009, Volume: 58, Issue:2

    Topics: Adolescent; Anticholesteremic Agents; Arginine; Azetidines; Biomarkers; Child; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Endothelium, Vascular; Ezetimibe; Female; Folic Acid; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Lipoproteins, LDL; Male; Risk Factors; Ultrasonography; Vitamin B Complex

2009
Detection of familial defective apolipoprotein B-100 among patients clinically diagnosed with heterozygous familial hypercholesterolemia in maritime Canada.
    Clinical biochemistry, 1994, Volume: 27, Issue:4

    Topics: Adult; Aged; Apolipoprotein B-100; Apolipoproteins B; Arginine; Canada; Electrophoresis, Polyacrylamide Gel; Female; Gene Expression Regulation; Glutamine; Heterozygote; Humans; Hyperlipoproteinemia Type II; Male; Middle Aged; Mutation; Phenotype; Polymerase Chain Reaction; Receptors, LDL; Restriction Mapping

1994
NO activity in familial combined hyperlipidemia: potential role of cholesterol remnants.
    Cardiovascular research, 1997, Volume: 36, Issue:3

    Topics: Adult; Arginine; Cholesterol; Endothelium, Vascular; Forearm; Humans; Hyperlipoproteinemia Type II; Hypolipidemic Agents; Lipoproteins; Male; Middle Aged; Nitric Oxide; Nitroprusside; Regional Blood Flow; Serotonin; Simvastatin; Vasodilation

1997

Other Studies

18 other study(ies) available for arginine and Hyperlipoproteinemia Type II

ArticleYear
Arginase inhibition improves endothelial function in patients with familial hypercholesterolaemia irrespective of their cholesterol levels.
    Journal of internal medicine, 2016, Volume: 279, Issue:5

    Topics: Adult; Arginase; Arginine; Blood Flow Velocity; Case-Control Studies; Cholesterol; Endothelium, Vascular; Enzyme Inhibitors; Forearm; Heterozygote; Humans; Hyperlipoproteinemia Type II; Male; Serotonin; Vasodilation

2016
Functional analysis of the p.(Leu15Pro) and p.(Gly20Arg) sequence changes in the signal sequence of LDL receptor.
    Atherosclerosis, 2016, Volume: 250

    Topics: Animals; Arginine; CHO Cells; Cricetinae; Cricetulus; Endoplasmic Reticulum; Glycine; Heterozygote; Humans; Hyperlipoproteinemia Type II; Leucine; Microscopy, Confocal; Mutation; Pedigree; Proline; Protein Folding; Protein Sorting Signals; Protein Structure, Secondary; Receptors, LDL

2016
Nitric oxide and endothelin after lipid apheresis - a pilot study.
    Atherosclerosis. Supplements, 2009, Dec-29, Volume: 10, Issue:5

    Topics: Adult; Aged; Analysis of Variance; Arginine; Atherosclerosis; Biomarkers; Blood Component Removal; Case-Control Studies; Citrulline; Endothelin-1; Female; Humans; Hyperlipoproteinemia Type II; Lipids; Male; Middle Aged; Nitric Oxide; Pilot Projects; Treatment Outcome

2009
Lipid-apheresis improves microcirculation of the upper limbs.
    Journal of clinical apheresis, 2011, Volume: 26, Issue:4

    Topics: Adult; Aged; Arginine; Atrial Natriuretic Factor; Blood Component Removal; Blood Flow Velocity; Endothelin-1; Epinephrine; Erythrocyte Aggregation; Female; Fibrinogen; Hand; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Laser-Doppler Flowmetry; Lipids; Male; Microcirculation; Microscopic Angioscopy; Middle Aged; Norepinephrine; Photoplethysmography

2011
Relationship between plasma coenzyme Q10, asymmetric dimethylarginine and arterial stiffness in patients with phenotypic or genotypic familial hypercholesterolemia on long-term statin therapy.
    Atherosclerosis, 2011, Volume: 218, Issue:1

    Topics: Aged; Arginine; Case-Control Studies; Chromatography, High Pressure Liquid; Female; Genotype; Heterozygote; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Male; Middle Aged; Mutation; Receptors, LDL; Ubiquinone; Vascular Stiffness

2011
Plasma asymmetric dimethylarginine and hyperemic myocardial blood flow in young subjects with borderline hypertension or familial hypercholesterolemia.
    Journal of the American College of Cardiology, 2002, Oct-02, Volume: 40, Issue:7

    Topics: Adult; Age Factors; Arginine; Biomarkers; Blood Flow Velocity; Case-Control Studies; Coronary Circulation; Cross-Sectional Studies; Dipyridamole; Humans; Hyperemia; Hyperlipoproteinemia Type II; Hypertension; Linear Models; Male; Multivariate Analysis; Nitric Oxide Synthase; Tomography, Emission-Computed; Vasodilator Agents

2002
Long-term combined beneficial effects of physical training and metabolic treatment on atherosclerosis in hypercholesterolemic mice.
    Proceedings of the National Academy of Sciences of the United States of America, 2004, Jun-08, Volume: 101, Issue:23

    Topics: Animals; Antioxidants; Arginine; Arteriosclerosis; Ascorbic Acid; Diet, Atherogenic; Hyperlipoproteinemia Type II; Male; Mice; Mice, Knockout; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Oxidative Stress; Physical Conditioning, Animal; Receptors, LDL; Vitamin E

2004
Phenotype of heterozygotes for low-density lipoprotein receptor mutations identified in different background populations.
    Arteriosclerosis, thrombosis, and vascular biology, 2005, Volume: 25, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amino Acid Substitution; Apolipoproteins B; Arginine; Bias; Cholesterol; Female; Genetic Carrier Screening; Genetics, Population; Glutamine; Humans; Hyperlipoproteinemia Type II; Male; Middle Aged; Mutation; Myocardial Ischemia; Phenotype; Receptors, LDL

2005
Glucagon release following experimental diets in man: effects of soybean and casein enriched diets.
    Pharmacological research communications, 1982, Volume: 14, Issue:9

    Topics: Adolescent; Adult; Arginine; Blood Glucose; Caseins; Cholesterol; Dietary Proteins; Glucagon; Glycine max; Humans; Hyperlipoproteinemia Type II; Insulin; Middle Aged; Time Factors; Triglycerides

1982
Vascular function in the forearm of hypercholesterolaemic patients off and on lipid-lowering medication.
    Lancet (London, England), 1995, Aug-19, Volume: 346, Issue:8973

    Topics: Adult; Arginine; Blood Pressure; Cholesterol; Cholestyramine Resin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Forearm; Humans; Hyperlipoproteinemia Type II; Hypolipidemic Agents; Infusions, Intravenous; Lovastatin; Male; Nitroprusside; omega-N-Methylarginine; Regional Blood Flow; Serotonin; Simvastatin; Vasodilation

1995
Independent mutation of arginine(3500)-->glutamine associated with familial defective apolipoprotein B-100.
    Journal of lipid research, 1993, Volume: 34, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Apolipoprotein B-100; Apolipoproteins B; Arginine; Base Sequence; Female; Genes, Dominant; Genetic Markers; Germany; Glutamine; Haplotypes; Humans; Hyperlipoproteinemia Type II; Lipoproteins, LDL; Male; Middle Aged; Molecular Sequence Data; Mutation; Pedigree; Structure-Activity Relationship

1993
Denaturing gradient-gel electrophoresis screening of familial defective apolipoprotein B-100 in a mixed Asian cohort: two cases of arginine3500-->tryptophan mutation associated with a unique haplotype.
    Clinical chemistry, 1997, Volume: 43, Issue:6 Pt 1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Apolipoprotein B-100; Apolipoproteins B; Apolipoproteins E; Arginine; Child; Child, Preschool; Cholesterol; Cholesterol, LDL; Codon; Cohort Studies; DNA Mutational Analysis; Electrophoresis, Polyacrylamide Gel; Ethnicity; Exons; Female; Genotype; Haplotypes; Humans; Hyperlipoproteinemia Type II; Male; Middle Aged; Mutation; Nucleic Acid Denaturation; Polymorphism, Genetic; Receptors, LDL; Tryptophan

1997
Identification of the low density lipoprotein receptor-binding site in apolipoprotein B100 and the modulation of its binding activity by the carboxyl terminus in familial defective apo-B100.
    The Journal of clinical investigation, 1998, Mar-01, Volume: 101, Issue:5

    Topics: Animals; Anura; Apolipoproteins B; Arginine; Base Sequence; Cells, Cultured; Chickens; Cloning, Molecular; DNA Primers; Gene Expression; Humans; Hyperlipoproteinemia Type II; Immunoassay; Lipoproteins, LDL; Lipoproteins, VLDL; Mice; Mice, Transgenic; Molecular Sequence Data; Mutagenesis, Site-Directed; Plasmids; Rabbits; Receptors, LDL; Recombinant Proteins; Recombination, Genetic; Sequence Alignment; Sequence Analysis

1998
Apolipoprotein E2 (Arg136 --> Cys) mutation in the receptor binding domain of apoE is not associated with dominant type III hyperlipoproteinemia.
    Journal of lipid research, 1998, Volume: 39, Issue:3

    Topics: Adult; Amino Acid Sequence; Apolipoprotein E2; Apolipoproteins E; Arginine; Base Sequence; Cells, Cultured; Cysteine; Female; Fibroblasts; Heterozygote; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type III; Lipoproteins, VLDL; Male; Middle Aged; Mutation; Polymorphism, Restriction Fragment Length; Receptors, LDL

1998
Nitric oxide production is reduced in patients with chronic renal failure.
    Arteriosclerosis, thrombosis, and vascular biology, 1999, Volume: 19, Issue:5

    Topics: Arginine; Arteriosclerosis; Blood Pressure; Cholesterol; Citrulline; Creatinine; Female; Humans; Hyperlipoproteinemia Type II; Kidney Failure, Chronic; Male; Nitric Oxide; Risk Factors; Smoking; Triglycerides

1999
Homozygous familial hypercholesterolemia: A novel point mutation (W556R) in a Turkish patient.
    Human mutation, 2000, Volume: 16, Issue:4

    Topics: Adult; Amino Acid Substitution; Arginine; Child, Preschool; Female; Homozygote; Humans; Hyperlipoproteinemia Type II; Point Mutation; Tryptophan; Turkey

2000
Serum L-arginine in hypercholesterolaemia.
    Lancet (London, England), 1992, Aug-22, Volume: 340, Issue:8817

    Topics: Adult; Aged; Arginine; Cholesterol; Humans; Hyperlipoproteinemia Type II; Middle Aged; Triglycerides

1992
Identification of a heterozygous compound individual with familial hypercholesterolemia and familial defective apolipoprotein B-100.
    Klinische Wochenschrift, 1991, May-03, Volume: 69, Issue:7

    Topics: Adolescent; Adult; Aged; Apolipoprotein B-100; Apolipoproteins B; Arginine; Base Sequence; Child; DNA, Circular; Female; Glutamine; Heterozygote; Humans; Hydroxymethylglutaryl CoA Reductases; Hyperlipoproteinemia Type II; Lipid Metabolism, Inborn Errors; Male; Middle Aged; Molecular Sequence Data; Mutation; Pedigree; Protein Binding

1991